Showing results (1431-1440 of 1,532) with videos related to

Sort By:
Pageof 154
Medrxiv : the Preprint Server for Health Sciences|April 12, 2022
Real World Evidence of the Neutralizing Monoclonal Antibody Sotrovimab for Preventing Hospitalization and Mortality in COVID-19 OutpatientsNeil R Aggarwal, Laurel E Beaty, Tellen D Bennett, et al.
The Journal of Clinical Investigation|October 26, 2023
Somatic estrogen receptor α mutations that induce dimerization promote receptor activity and breast cancer proliferationSeema Irani, Wuwei Tan, Qing Li, et al.
Bioorganic & Medicinal Chemistry Letters|March 20, 2003
Discovery of 4'-[(imidazol-1-yl)methyl]biphenyl-2-sulfonamides as dual endothelin/angiotensin II receptor antagonistsJohn E Tellew, Rose Ann F Baska, Sophie M Beyer, et al.
BMC Genomics|August 4, 2009
Comparison of next generation sequencing technologies for transcriptome characterizationP Kerr Wall, Jim Leebens-Mack, André S Chanderbali, et al.
Journal of the American Heart Association|August 2, 2015
Left Ventricular Dilatation Increases the Risk of Ventricular Arrhythmias in Patients With Reduced Systolic FunctionRyan G Aleong, Matthew J Mulvahill, Indrani Halder, et al.
European Journal of Medicinal Chemistry|August 26, 2018
Discovery of long-chain salicylketoxime derivatives as monoacylglycerol lipase (MAGL) inhibitorsGiulia Bononi, Carlotta Granchi, Margherita Lapillo, et al.
Plos One|September 28, 2019
Microbiota of MR1 deficient mice confer resistance against Clostridium difficile infectionAshley D Smith, Elissa D Foss, Irma Zhang, et al.
Fungal Biology|May 8, 2012
The mitochondrial genome of Moniliophthora roreri, the frosty pod rot pathogen of cacaoGustavo G L Costa, Odalys G Cabrera, Ricardo A Tiburcio, et al.
Molecular Cancer Research : MCR|September 22, 2022
Molecular Profile Changes in Patients with Castrate-Resistant Prostate Cancer Pre- and Post-Abiraterone/Prednisone TreatmentHugues Sicotte, Krishna R Kalari, Sisi Qin, et al.
Psycho-Oncology|October 8, 2025
Investigating the Pre-Implementation Facilitators and Barriers of the Implementation of the Fear of Recurrence Therapy (FORT) Intervention in Canadian Cancer CentersSophie Lebel, Alanna Chu, Florence Gourgues, et al.
Pageof 154